237 related articles for article (PubMed ID: 11982504)
1. Increased phasic activity of dopaminergic neurones in the rat ventral tegmental area following pharmacologically elevated levels of endogenous kynurenic acid.
Erhardt S; Engberg G
Acta Physiol Scand; 2002 May; 175(1):45-53. PubMed ID: 11982504
[TBL] [Abstract][Full Text] [Related]
2. Activation of rat ventral tegmental area dopamine neurons by endogenous kynurenic acid: a pharmacological analysis.
Linderholm KR; Andersson A; Olsson S; Olsson E; Snodgrass R; Engberg G; Erhardt S
Neuropharmacology; 2007 Dec; 53(8):918-24. PubMed ID: 17959203
[TBL] [Abstract][Full Text] [Related]
3. Effects of COX-1 and COX-2 inhibitors on the firing of rat midbrain dopaminergic neurons--possible involvement of endogenous kynurenic acid.
Schwieler L; Erhardt S; Nilsson L; Linderholm K; Engberg G
Synapse; 2006 Apr; 59(5):290-8. PubMed ID: 16416446
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory action of clozapine on rat ventral tegmental area dopamine neurons following increased levels of endogenous kynurenic acid.
Schwieler L; Erhardt S
Neuropsychopharmacology; 2003 Oct; 28(10):1770-7. PubMed ID: 12865892
[TBL] [Abstract][Full Text] [Related]
5. Clozapine interacts with the glycine site of the NMDA receptor: electrophysiological studies of dopamine neurons in the rat ventral tegmental area.
Schwieler L; Linderholm KR; Nilsson-Todd LK; Erhardt S; Engberg G
Life Sci; 2008 Aug; 83(5-6):170-5. PubMed ID: 18590745
[TBL] [Abstract][Full Text] [Related]
6. Elevated levels of kynurenic acid change the dopaminergic response to amphetamine: implications for schizophrenia.
Olsson SK; Andersson AS; Linderholm KR; Holtze M; Nilsson-Todd LK; Schwieler L; Olsson E; Larsson K; Engberg G; Erhardt S
Int J Neuropsychopharmacol; 2009 May; 12(4):501-12. PubMed ID: 18796185
[TBL] [Abstract][Full Text] [Related]
7. Excitatory and inhibitory responses of dopamine neurons in the ventral tegmental area to nicotine.
Erhardt S; Schwieler L; Engberg G
Synapse; 2002 Mar; 43(4):227-37. PubMed ID: 11835517
[TBL] [Abstract][Full Text] [Related]
8. Kynurenic acid and schizophrenia.
Erhardt S; Schwieler L; Engberg G
Adv Exp Med Biol; 2003; 527():155-65. PubMed ID: 15206728
[TBL] [Abstract][Full Text] [Related]
9. Clozapine modulates midbrain dopamine neuron firing via interaction with the NMDA receptor complex.
Schwieler L; Engberg G; Erhardt S
Synapse; 2004 May; 52(2):114-22. PubMed ID: 15034917
[TBL] [Abstract][Full Text] [Related]
10. Intracerebroventricular administration of NMDA-R1 antisense oligodeoxynucleotide significantly alters the activity of ventral tegmental area dopamine neurons: an electrophysiological study.
Tajiri K; Emori K; Murata M; Tanaka K; Suzuki M; Uehara T; Sumiyoshi T; Ashby CR; Kurachi M
Synapse; 2001 Jun; 40(4):275-81. PubMed ID: 11309843
[TBL] [Abstract][Full Text] [Related]
11. Nicotine-induced excitation of locus coeruleus neurons is blocked by elevated levels of endogenous kynurenic acid.
Erhardt S; Hajos M; Lindberg A; Engberg G
Synapse; 2000 Aug; 37(2):104-8. PubMed ID: 10881031
[TBL] [Abstract][Full Text] [Related]
12. Excitatory amino acid-induced excitation of dopamine-containing neurons in the rat substantia nigra: modulation by kynurenic acid.
Wu HQ; Schwarcz R; Shepard PD
Synapse; 1994 Mar; 16(3):219-30. PubMed ID: 7515199
[TBL] [Abstract][Full Text] [Related]
13. The kynurenic acid hypothesis of schizophrenia.
Erhardt S; Schwieler L; Nilsson L; Linderholm K; Engberg G
Physiol Behav; 2007 Sep; 92(1-2):203-9. PubMed ID: 17573079
[TBL] [Abstract][Full Text] [Related]
14. Endogenous kynurenic acid disrupts prepulse inhibition.
Erhardt S; Schwieler L; Emanuelsson C; Geyer M
Biol Psychiatry; 2004 Aug; 56(4):255-60. PubMed ID: 15312813
[TBL] [Abstract][Full Text] [Related]
15. Kynurenic acid analogues with improved affinity and selectivity for the glycine site on the N-methyl-D-aspartate receptor from rat brain.
Foster AC; Kemp JA; Leeson PD; Grimwood S; Donald AE; Marshall GR; Priestley T; Smith JD; Carling RW
Mol Pharmacol; 1992 May; 41(5):914-22. PubMed ID: 1375317
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological elevation of endogenous kynurenic acid levels activates nigral dopamine neurons.
Erhardt S; Oberg H; Mathé JM; Engberg G
Amino Acids; 2001; 20(4):353-62. PubMed ID: 11452979
[TBL] [Abstract][Full Text] [Related]
17. Bifeprunox and aripiprazole suppress in vivo VTA dopaminergic neuronal activity via D2 and not D3 dopamine autoreceptor activation.
Etievant A; Bétry C; Arnt J; Haddjeri N
Neurosci Lett; 2009 Aug; 460(1):82-6. PubMed ID: 19450663
[TBL] [Abstract][Full Text] [Related]
18. Activation of noradrenergic locus coeruleus neurons by clozapine and haloperidol: involvement of glutamatergic mechanisms.
Nilsson LK; Schwieler L; Engberg G; Linderholm KR; Erhardt S
Int J Neuropsychopharmacol; 2005 Sep; 8(3):329-39. PubMed ID: 15737250
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of kynurenine aminotransferase II reduces activity of midbrain dopamine neurons.
Linderholm KR; Alm MT; Larsson MK; Olsson SK; Goiny M; Hajos M; Erhardt S; Engberg G
Neuropharmacology; 2016 Mar; 102():42-7. PubMed ID: 26514401
[TBL] [Abstract][Full Text] [Related]
20. Modulation of striatal quinolinate neurotoxicity by elevation of endogenous brain kynurenic acid.
Harris CA; Miranda AF; Tanguay JJ; Boegman RJ; Beninger RJ; Jhamandas K
Br J Pharmacol; 1998 May; 124(2):391-9. PubMed ID: 9641558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
